BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35648375)

  • 1. Differential influence of YAP1 and TAZ on differentiation of intestinal epithelial cell: A review.
    Fallah S; Beaulieu JF
    Anat Rec (Hoboken); 2023 May; 306(5):1054-1061. PubMed ID: 35648375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation.
    Fallah S; Beaulieu JF
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src family kinases inhibit differentiation of intestinal epithelial cells through the Hippo effector YAP1.
    Fallah S; Beaulieu JF
    Biol Open; 2021 Nov; 10(11):. PubMed ID: 34693980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
    Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
    J Cell Sci; 2024 May; 137(10):. PubMed ID: 38639242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
    Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
    J Cell Sci; 2024 May; 137(10):. PubMed ID: 38813860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.
    Kodaka M; Hata Y
    Cell Mol Life Sci; 2015 Jan; 72(2):285-306. PubMed ID: 25266986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells.
    Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A
    FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity.
    Yuan Y; Park J; Feng A; Awasthi P; Wang Z; Chen Q; Iglesias-Bartolome R
    Nat Commun; 2020 Mar; 11(1):1472. PubMed ID: 32193376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
    Nagashima S; Bao Y; Hata Y
    Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation.
    Luo J; Li P
    Stem Cell Res Ther; 2022 Jan; 13(1):10. PubMed ID: 35012640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma.
    Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R
    J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of YAP and TAZ in renewal of the intestinal epithelium.
    Imajo M; Ebisuya M; Nishida E
    Nat Cell Biol; 2015 Jan; 17(1):7-19. PubMed ID: 25531778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation.
    Damkham N; Lorthongpanich C; Klaihmon P; Lueangamornnara U; Kheolamai P; Trakarnsanga K; Issaragrisil S
    Stem Cell Res Ther; 2022 Sep; 13(1):467. PubMed ID: 36076260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of
    Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
    Development; 2018 Mar; 145(6):. PubMed ID: 29511023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function.
    Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS
    Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
    Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
    J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population.
    Liu R; Wei C; Ma Q; Wang W
    Pregnancy Hypertens; 2020 Jan; 19():1-10. PubMed ID: 31841877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP/TAZ maintain the proliferative capacity and structural organization of radial glial cells during brain development.
    Lavado A; Gangwar R; Paré J; Wan S; Fan Y; Cao X
    Dev Biol; 2021 Dec; 480():39-49. PubMed ID: 34419458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior.
    van Soldt BJ; Cardoso WV
    Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e371. PubMed ID: 31828974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.